Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth J Perlman

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 21, 2019
Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 studyNajat C Daw, Yueh-Yun Chi, Yeonil Kim, et al.
AJR. American Journal of Roentgenology|March 12, 2020
Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2Jesse K Sandberg, Yueh-Yun Chi, Ethan A Smith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
Authors' Reply to the Letter to the Editor by Daniel M. GreenJeffrey S Dome, Elizabeth A Mullen, David B Dix, et al.
Blood|September 21, 2006
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology GroupSmita Bhatia, Mark D Krailo, Zhengjia Chen, et al.
Plos One|June 23, 2012
Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic studyJan Marc Orenstein, Stanford T Shulman, Linda M Fox, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 20, 2021
Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms TumorJeffrey S Dome, Elizabeth A Mullen, David B Dix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2023
Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of ChemotherapyNatanja Oosterom, Saskia L M Gooskens, Lindsay A Renfro, et al.
Pediatric Blood & Cancer|September 17, 2013
Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study GroupDaniel M Green, Norman E Breslow, Giulio J D'Angio, et al.
The New England Journal of Medicine|February 21, 2003
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of boneHolcombe E Grier, Mark D Krailo, Nancy J Tarbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882Barbara Cushing, Roger Giller, John W Cullen, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|July 21, 2019
Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 studyNajat C Daw, Yueh-Yun Chi, Yeonil Kim, et al.
AJR. American Journal of Roentgenology|March 12, 2020
Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2Jesse K Sandberg, Yueh-Yun Chi, Ethan A Smith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
Authors' Reply to the Letter to the Editor by Daniel M. GreenJeffrey S Dome, Elizabeth A Mullen, David B Dix, et al.
Blood|September 21, 2006
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology GroupSmita Bhatia, Mark D Krailo, Zhengjia Chen, et al.
Plos One|June 23, 2012
Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic studyJan Marc Orenstein, Stanford T Shulman, Linda M Fox, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 20, 2021
Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms TumorJeffrey S Dome, Elizabeth A Mullen, David B Dix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2023
Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of ChemotherapyNatanja Oosterom, Saskia L M Gooskens, Lindsay A Renfro, et al.
Pediatric Blood & Cancer|September 17, 2013
Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study GroupDaniel M Green, Norman E Breslow, Giulio J D'Angio, et al.
The New England Journal of Medicine|February 21, 2003
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of boneHolcombe E Grier, Mark D Krailo, Nancy J Tarbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882Barbara Cushing, Roger Giller, John W Cullen, et al.
Pageof 13